Key result
Transvenous lead extraction in patients with persistent left superior vena cava achieved 100% complete procedural success with no complications and no 30-day mortality.
Why the study?
Transvenous lead extraction is increasing, but its performance in patients with persistent left superior vena cava is rare.
Is transvenous lead extraction safe and feasible in patients with persistent left superior vena cava?
Observational (n=10)
Yes
Is transvenous lead extraction safe and feasible in patients with persistent left superior vena cava?
Transvenous lead extraction in patients with persistent left superior vena cava is feasible and safe when performed by experienced operators.
Supports feasibility in persistent left SVC; leaves open larger prospective validation before practice change.
BACKGROUND: Transvenous lead extraction (TLE) is rising in parallel to cardiac implantable electronic device implantations. Persistent left side superior vena cava (PLSVC) is a relatively common anatomical variant in the healthy population; TLE in patients with a PLSVC is rare. METHOD: Data were collated from 6 European TLE institutes of 10 patients who had undergone lead extraction with a PLSVC. Patient demographics, procedural challenges and outcomes were reported. RESULTS: Ten patients aged 73.4 ± 7.8 years (60% male) underwent TLE of 20 leads (3 left ventricle, 10 right ventricle, 7 right atrium) with dwell time of 82.95 ± 39.1 months. Of the 10 cases, 4 had an infection indication and 5 were biventricular system extractions; 25% of the extracted leads were defibrillator leads. The majority of the procedures were completed in the cardiac catheterization suite (80%) under general anaesthesia (60%) by cardiologists (80%) using a rotational powered sheath (65%). The Tandem approach was used successfully in 3 cases. Complete procedural success was obtained in 100% of cases in the absence of complications within 127.4 ± 74.7 min. There was no 30-day mortality. CONCLUSION: TLE in PLSVC is feasible albeit rare. Standard extraction techniques in experienced hands are associated with favorable outcomes; the Tandem procedure may be an additional technique to improve the safety and efficacy of TLE in PLSVC.
No takes yet. Share an insight, caveat, or question.
Akhtar et al. (2021) conducted an observational in Persistent left side superior vena cava requiring transvenous lead extraction (n=10). Transvenous lead extraction was evaluated on Complete procedural success. Transvenous lead extraction in patients with persistent left superior vena cava achieved 100% complete procedural success with no complications and no 30-day mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: